Concepedia

Revathi Kodali

RK

Statistics

Publications

11

Citations

348

H-Index

11

Active since

2016

Affiliations

University of Wisconsin–Milwaukee(Current)

Columbia University

Medical University of Vienna

Marquette University

University of South Carolina

Revathi Kodali is an author at University of Wisconsin–Milwaukee specializing in pharmacotherapy, drug discovery, and medicine.

Top concepts

Publications per year

2016–2019

11

Publications

11

Novel Benzodiazepine-Like Ligands with Various Anxiolytic, Antidepressant, or Pro-Cognitive Profiles

Thomas D. Prévot, Guanguan Li, Aleksandra Vidojević et al. · Complex Psychiatry · 2019 · 91 citations · Full text

, , +21

Design and Synthesis of Novel Deuterated Ligands Functionally Selective for the γ-Aminobutyric Acid Type A Receptor (GABA<sub>A</sub>R) α6 Subtype with Improved Metabolic Stability and Enhanced Bioavailability

Daniel E. Knutson, Revathi Kodali, Branka Divović et al. · Journal of Medicinal Chemistry · 2018 · 51 citations · Full text

A Novel Orally Available Asthma Drug Candidate That Reduces Smooth Muscle Constriction and Inflammation by Targeting GABA<sub>A</sub> Receptors in the Lung

Gloria S. Forkuo, Amanda N. Nieman, Revathi Kodali et al. · Molecular Pharmaceutics · 2018 · 40 citations · Full text

Development of GABA<sub>A</sub> Receptor Subtype-Selective Imidazobenzodiazepines as Novel Asthma Treatments

Gloria S. Forkuo, Margaret L. Guthrie, Nina Y. Yuan et al. · Molecular Pharmaceutics · 2016 · 29 citations · Full text

Alleviation of Multiple Asthmatic Pathologic Features with Orally Available and Subtype Selective GABA<sub>A</sub> Receptor Modulators

Gloria S. Forkuo, Amanda N. Nieman, Nina Y. Yuan et al. · Molecular Pharmaceutics · 2017 · 29 citations

1–5 of 11